Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy

Lorenzo G.R. Romano,Lize F.D. van Vulpen,Paul L. den Exter,Floor C.J.I. Heubel-Moenen, Helene L. Hooijmeijer,Michiel Coppens,Karin Fijnvandraat,Saskia E.M. Schols,Paula F. Ypma,Cees Smit,Mariëtte H.E. Driessens,Frits R. Rosendaal,Johanna G. van der Bom,Samantha C. Gouw,Marieke J.H.A. Kruip

Research and Practice in Thrombosis and Haemostasis（2023）

引用 0|浏览12

暂无评分

摘要

•In nonsevere hemophilia A, desmopressin is an established but underused treatment option.•We assessed patients’ perspectives on desmopressin use in a multicenter study.•Desmopressin was most often used intranasally and considered at least moderately effective by 90% of patients.•Flushing was the most common side effect in 26% of the adults and 31% of the children.

查看译文

关键词

advantages,desmopressin,hemophilia A,patient perspective,side effects,survey

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要